Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Melatonin and angiogenesis potential in stem cells

Rashidi S., Chegeni SA., Roozbahani G., Rahbarghazi R., Rezabakhsh A., Reiter RJ.

Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Stem Cell Res Ther (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40764577
PMCID
PMC12326606
DOI
10.1186/s13287-025-04531-y
Citations
1

Abstract (original English)

Ischemic diseases, especially coronary artery diseases and myocardial infarction, are the leading cause of human death in the clinical setting. Unfortunately, most of the available clinical interventions can partially restore the function of ischemic myocardium, resulting in the progression of chronic heart failure.The induction of vascular tissue formation, hereafter known as angiogenesis, can provide blood perfusion and prevent the expansion of ischemia-related pathologies. In recent years, the discovery and advent of multiple stem cells into human regenerative medicine have led to the alleviation of certain end-stage pathological conditions via direct differentiation into the mature and functional cells or secretion of various cytokines and angiogenesis factors in a paracrine manner. Melatonin (mel) is a natural molecule with direct and indirect pleiotropic actions on different biological phenomena. This neurohormone is primarily known for its antioxidant, tumoricidal, and anti-inflammatory actions in several pathological conditions. Whether and how mel regulates the angiogenesis behavior of stem cells is currently under debate. Here, we collected and evaluated recent data related to the angiogenic properties of mel on stem cells. Data from the present article may help us in the development of new therapeutic regimes in patients with ischemic conditions.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Stem CellsAnimalsHumansIschemiaMelatoninAngiogenesis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research